Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › AZ › Phoenix › NPI 1740262880
Lab

Laboratory Corporation of America

Laboratory Corporation of America was paid $265.90M by Medicaid between Jan 2018 and Dec 2024, across 598 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 30% of everything it billed.

33Billing provider infoLABORATORY CORPORATION OF AMERICA
PHOENIX, AZ 85040
33aNPI1740262880assigned 11/15/2005
33bProvider typeClinical Medical Laboratory
28Total paid$265.90M
24GClaims31,036,545
24DCodes billed598
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in Arizona

Rank by total paid#2 of 67
Median peer was paid$89K
This provider vs. median2,979×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$5.0M$10M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20184,076,225$16.30M
20193,701,207$20.12M
20203,906,841$51.77M
20214,908,059$62.67M
20224,881,222$45.30M
20234,941,431$34.56M
2024incomplete4,621,560$35.17M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 30% 1,134,640 1,000,025 $79.91M
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 9.3% 878,446 518,728 $24.69M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 8.1% 1,240,450 1,166,662 $21.55M
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 7.7% 1,241,057 1,167,177 $20.53M
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 7.6% 542,779 518,922 $20.18M
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 5.0% 758,828 718,772 $13.21M
80050 General health panel 2.7% 286,491 264,115 $7.11M
86003 2.0% 117,381 104,142 $5.30M
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 1.6% 236,649 198,484 $4.26M
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 1.2% 674,402 644,399 $3.10M
80061 Lipid panel 1.1% 1,368,148 1,315,685 $3.03M
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 191,615 184,188 $2.62M
586 more codes
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 273,953 $2.44M
80053 Comprehensive metabolic panel <1% 1,664,750 $2.42M
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 1,649,289 $2.10M
87507 <1% 9,214 $2.06M
83036 Hemoglobin; glycosylated (A1C) <1% 1,112,804 $1.83M
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 363,173 $1.77M
84443 Thyroid stimulating hormone (TSH) <1% 1,047,688 $1.66M
83013 <1% 60,171 $1.54M
80081 <1% 35,516 $1.42M
84439 <1% 530,890 $1.39M
80074 <1% 105,387 $1.38M
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 48,705 $1.30M
87086 Culture, bacterial; quantitative colony count, urine <1% 541,473 $1.28M
86235 <1% 39,312 $1.27M
81420 Fetal chromosomal aneuploidy genomic sequence analysis panel <1% 8,080 $1.26M
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 13,414 $1.14M
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 13,249 $1.11M
86480 <1% 56,917 $1.05M
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 26,847 $1.03M
87536 <1% 37,986 $979K
87529 <1% 42,860 $919K
86803 <1% 236,505 $850K
82607 <1% 312,643 $815K
86769 <1% 25,953 $707K
84403 <1% 155,459 $682K
87563 <1% 36,419 $573K
36415 Collection of venous blood by venipuncture <1% 746,186 $534K
86038 <1% 123,288 $500K
82746 <1% 215,756 $492K
82785 <1% 69,971 $490K
88142 <1% 46,667 $490K
84402 <1% 97,089 $476K
82728 <1% 215,149 $460K
86008 <1% 13,440 $460K
84481 <1% 142,533 $449K
82670 <1% 89,676 $444K
87522 Neg quan hep c or qual rna <1% 39,162 $425K
87481 <1% 20,170 $405K
83001 <1% 100,514 $387K
87340 <1% 174,045 $356K
86592 <1% 391,142 $355K
84153 <1% 130,202 $351K
86696 <1% 74,200 $339K
87081 <1% 201,498 $332K
87150 <1% 46,966 $327K
87480 <1% 64,493 $290K
86147 <1% 14,108 $284K
87186 <1% 159,665 $279K
83550 <1% 208,607 $276K
86225 <1% 42,254 $267K
87902 <1% 6,601 $265K
83002 <1% 84,426 $265K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 238,361 $263K
87088 <1% 156,902 $261K
84702 <1% 106,318 $257K
84146 <1% 76,549 $255K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 6,324 $251K
83970 <1% 50,304 $248K
87070 <1% 74,749 $246K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants <1% 5,501 $246K
81001 <1% 350,679 $243K
82043 <1% 250,083 $243K
87510 <1% 64,497 $240K
87660 <1% 63,715 $240K
85027 <1% 135,521 $235K
83540 <1% 238,052 $223K
86146 <1% 11,189 $222K
88141 <1% 34,544 $222K
82570 <1% 250,783 $215K
86376 <1% 71,903 $215K
84144 <1% 53,095 $211K
86695 <1% 65,286 $209K
84480 <1% 60,744 $208K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 4,424 $198K
84445 <1% 11,298 $173K
88185 <1% 2,747 $169K
86780 <1% 28,969 $166K
86360 <1% 14,269 $163K
87517 <1% 8,669 $162K
84436 <1% 120,996 $161K
87077 <1% 75,457 $159K
80048 Basic metabolic panel (calcium, ionized) <1% 127,035 $151K
82627 <1% 36,788 $147K
83525 <1% 72,818 $147K
86787 <1% 23,311 $144K
86361 <1% 18,759 $139K
86706 <1% 58,445 $131K
83735 <1% 121,542 $129K
86800 <1% 45,289 $128K
86704 <1% 45,372 $127K
82274 <1% 39,802 $122K
87625 <1% 6,982 $121K
86140 <1% 162,119 $120K
86665 <1% 15,050 $120K
80076 <1% 72,561 $110K
87209 <1% 21,970 $101K
83880 <1% 15,831 $97K
86431 <1% 71,077 $95K
87045 <1% 19,951 $95K
82784 <1% 60,171 $94K
82533 <1% 30,178 $92K
82024 <1% 11,927 $91K
88112 <1% 4,880 $91K
84550 <1% 105,962 $90K
82950 <1% 86,472 $90K
82105 <1% 39,781 $89K
84479 <1% 61,058 $84K
85652 <1% 184,618 $83K
86708 <1% 26,514 $82K
86762 <1% 76,434 $80K
88304 <1% 5,924 $80K
86160 <1% 22,139 $80K
88342 <1% 3,955 $79K
36416 <1% 13,656 $78K
86200 <1% 34,992 $77K
85610 <1% 103,283 $77K
82977 <1% 46,313 $77K
88307 <1% 1,219 $72K
85060 <1% 11,639 $70K
87177 <1% 22,171 $69K
84270 <1% 14,259 $66K
82672 <1% 18,399 $66K
84681 <1% 19,127 $63K
83516 <1% 33,778 $63K
85730 <1% 55,430 $61K
82565 <1% 62,125 $61K
87999 <1% 1,843 $61K
85613 <1% 13,599 $60K
84100 <1% 63,149 $59K
84165 <1% 18,543 $59K
85246 <1% 7,250 $59K
83615 <1% 58,484 $59K
86850 <1% 93,513 $58K
85245 <1% 7,122 $58K
87338 <1% 19,759 $57K
87799 <1% 5,874 $56K
83655 <1% 65,137 $55K
88341 <1% 1,862 $55K
86677 <1% 6,694 $54K
82378 <1% 19,740 $53K
85240 <1% 7,934 $53K
86664 <1% 11,341 $53K
82951 <1% 21,835 $52K
87427 <1% 19,983 $50K
80055 <1% 2,030 $50K
84154 <1% 20,904 $49K
83690 <1% 47,382 $49K
86317 <1% 12,767 $48K
82310 <1% 48,767 $48K
80051 <1% 19,689 $48K
87631 <1% 725 $46K
86635 <1% 33,333 $46K
86304 <1% 10,936 $45K
84520 <1% 56,125 $44K
82040 <1% 43,346 $42K
82248 <1% 29,099 $41K
81003 <1% 172,398 $41K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed <1% 808 $40K
86300 <1% 11,085 $40K
88312 <1% 2,046 $39K
84466 <1% 16,027 $39K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 1,340 $38K
82652 <1% 14,022 $38K
85306 <1% 5,090 $37K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 2,434 $37K
80069 <1% 41,595 $37K
87497 <1% 3,865 $36K
82103 <1% 8,995 $36K
86870 <1% 2,614 $36K
84478 <1% 19,335 $34K
83090 <1% 13,376 $34K
86359 <1% 5,156 $33K
82150 <1% 32,811 $33K
83520 <1% 16,227 $33K
84156 <1% 74,909 $32K
86735 <1% 8,656 $32K
80164 <1% 15,737 $32K
85732 <1% 11,224 $32K
84305 <1% 11,858 $31K
86900 <1% 92,930 $31K
82550 <1% 28,772 $30K
82247 <1% 52,113 $30K
84450 <1% 54,862 $30K
86334 <1% 12,398 $29K
87075 <1% 15,273 $29K
87046 <1% 20,050 $29K
86593 <1% 16,606 $29K
83498 <1% 7,437 $28K
82947 <1% 56,714 $28K
86709 <1% 10,467 $27K
86141 <1% 18,730 $27K
82465 <1% 17,733 $26K
81241 <1% 3,363 $25K
87535 <1% 4,383 $24K
84703 <1% 17,134 $23K
85007 <1% 10,576 $23K
87900 <1% 541 $23K
81374 <1% 6,102 $23K
85014 <1% 31,917 $23K
85598 <1% 4,883 $23K
84460 <1% 31,131 $22K
84425 <1% 11,937 $22K
87324 <1% 9,084 $22K
86901 <1% 92,960 $22K
87901 <1% 214 $22K
85303 <1% 4,063 $22K
84075 <1% 43,548 $21K
82626 <1% 6,339 $21K
86705 <1% 13,731 $21K
80197 <1% 14,077 $20K
84432 <1% 4,623 $20K
84155 <1% 52,562 $20K
86364 <1% 16,624 $20K
83021 <1% 4,110 $19K
86663 <1% 5,182 $19K
83721 <1% 21,223 $19K
87255 <1% 3,727 $19K
83521 <1% 4,231 $19K
86765 <1% 9,413 $19K
83993 <1% 7,613 $19K
82140 <1% 8,277 $19K
84207 <1% 5,609 $18K
86381 <1% 4,011 $18K
88184 <1% 2,404 $18K
80178 <1% 12,313 $18K
82390 <1% 9,231 $18K
85705 <1% 3,698 $18K
84999 <1% 415 $17K
88189 <1% 1,983 $17K
85300 <1% 3,834 $17K
85670 <1% 8,303 $17K
84295 <1% 30,846 $16K
85045 <1% 21,730 $16K
85379 <1% 8,115 $16K
84482 <1% 8,336 $16K
81240 <1% 2,340 $16K
82679 <1% 4,097 $16K
82435 <1% 30,288 $16K
82731 <1% 1,292 $16K
86702 <1% 4,951 $16K
87329 <1% 6,436 $15K
81329 <1% 3,150 $15K
83921 <1% 7,592 $15K
82104 <1% 2,848 $14K
88262 <1% 1,107 $14K
86644 <1% 4,167 $13K
86301 <1% 5,772 $13K
99001 <1% 10,884 $13K
82985 <1% 5,540 $13K
82088 <1% 3,745 $13K
88230 <1% 1,068 $12K
85660 <1% 7,791 $12K
83020 <1% 4,607 $12K
87493 <1% 2,241 $12K
84132 <1% 28,397 $12K
86701 <1% 4,671 $12K
83014 <1% 7,863 $11K
87210 <1% 9,159 $11K
82397 <1% 3,817 $11K
86341 <1% 3,771 $11K
86256 <1% 3,389 $11K
86258 <1% 6,268 $11K
86005 <1% 4,511 $11K
86015 <1% 4,498 $11K
82677 <1% 8,202 $10K
86694 <1% 3,753 $10K
82157 <1% 2,609 $10K
85305 <1% 2,589 $10K
81596 <1% 2,573 $10K
82330 <1% 8,067 $10K
84134 <1% 5,578 $10K
86645 <1% 3,806 $10K
0097U <1% 382 $9K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed <1% 67 $9K
87538 <1% 2,894 $9K
82952 <1% 16,912 $9K
86037 <1% 1,562 $9K
81270 <1% 1,467 $9K
82787 <1% 2,356 $9K
87040 <1% 2,889 $9K
84410 <1% 2,013 $9K
81206 <1% 813 $9K
82172 <1% 4,546 $9K
85302 <1% 2,017 $9K
82239 <1% 4,436 $9K
87521 Neg quan hep c or qual rna <1% 1,814 $8K
81361 <1% 1,528 $8K
87634 <1% 199 $8K
87350 <1% 7,041 $8K
81479 Unlisted molecular pathology procedure <1% 1,634 $8K
84630 <1% 10,660 $8K
81207 <1% 800 $8K
86777 <1% 2,276 $8K
83010 <1% 5,810 $8K
81257 <1% 1,710 $8K
87205 <1% 7,620 $8K
82653 <1% 1,904 $8K
85247 <1% 801 $7K
86162 <1% 2,569 $7K
82681 <1% 942 $7K
86618 <1% 2,139 $7K
82107 <1% 1,368 $7K
84244 <1% 3,787 $7K
86060 <1% 6,362 $7K
80159 <1% 4,174 $7K
84080 <1% 2,923 $7K
82374 <1% 4,680 $7K
82166 <1% 727 $6K
86336 <1% 12,165 $6K
85018 <1% 36,226 $6K
80156 <1% 3,083 $6K
84166 <1% 3,668 $6K
86337 <1% 1,670 $6K
86707 <1% 5,765 $6K
88164 <1% 1,085 $6K
82525 <1% 6,939 $6K
82553 <1% 2,374 $6K
81025 <1% 8,399 $6K
81229 <1% 1,004 $6K
85597 <1% 1,794 $6K
86335 <1% 2,010 $6K
85301 <1% 1,108 $6K
83883 <1% 6,843 $6K
82668 <1% 2,928 $6K
85384 <1% 2,489 $5K
81243 <1% 2,952 $5K
81256 <1% 2,048 $5K
82232 <1% 3,154 $5K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 227 $5K
82747 <1% 2,043 $5K
87650 <1% 1,420 $5K
87906 <1% 123 $5K
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) <1% 1,215 $5K
84484 <1% 2,199 $5K
83003 <1% 1,700 $5K
80177 <1% 4,853 $5K
86357 <1% 1,033 $5K
86355 <1% 1,036 $4K
80185 <1% 1,578 $4K
84590 <1% 7,494 $4K
87184 <1% 1,674 $4K
88173 <1% 177 $4K
86308 <1% 4,580 $4K
86778 <1% 1,391 $4K
85307 <1% 531 $4K
87593 <1% 195 $4K
81255 <1% 1,527 $4K
G0307 Complete (cbc), automated (hgb, hct, rbc, wbc; without platelet count) <1% 2,064 $4K
80299 <1% 2,104 $4K
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision <1% 4,405 $4K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 295 $4K
87328 <1% 1,780 $4K
83519 <1% 2,052 $4K
86738 <1% 2,920 $4K
81251 <1% 1,529 $3K
82705 <1% 1,604 $3K
82542 <1% 1,692 $3K
83631 <1% 1,995 $3K
83695 <1% 2,300 $3K
81200 <1% 1,529 $3K
86231 <1% 9,463 $3K
81330 <1% 1,524 $3K
83789 <1% 1,107 $3K
89055 <1% 2,958 $3K
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 3,446 $3K
82610 <1% 2,830 $3K
86880 <1% 2,145 $3K
86255 <1% 12,457 $3K
89321 <1% 823 $3K
84446 <1% 3,710 $3K
82941 <1% 431 $3K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 885 $3K
82575 <1% 3,088 $3K
86671 <1% 2,002 $3K
81260 <1% 1,525 $3K
82085 <1% 3,334 $3K
85004 <1% 2,234 $3K
81290 <1% 1,524 $3K
80175 <1% 3,124 $3K
81209 <1% 1,527 $3K
85250 <1% 308 $3K
81242 <1% 1,527 $3K
87109 <1% 1,733 $3K
80202 <1% 2,523 $3K
82308 <1% 260 $3K
84140 <1% 981 $3K
82164 <1% 1,928 $2K
83835 <1% 2,379 $2K
83625 <1% 2,217 $2K
82340 <1% 3,270 $2K
81291 <1% 1,294 $2K
82945 <1% 1,150 $2K
87076 <1% 1,368 $2K
85220 <1% 197 $2K
87101 <1% 3,542 $2K
83718 <1% 1,647 $2K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 58 $2K
84157 <1% 1,180 $2K
85049 <1% 2,309 $2K
80183 <1% 2,142 $2K
G0306 Complete cbc, automated (hgb, hct, rbc, wbc, without platelet count) and automated wbc differential count <1% 734 $2K
84255 <1% 1,286 $2K
82552 <1% 1,036 $2K
85048 <1% 9,017 $2K
82642 <1% 400 $2K
84378 <1% 6,130 $2K
82955 <1% 871 $2K
83704 <1% 1,572 $2K
86356 <1% 490 $2K
85270 <1% 171 $2K
86036 <1% 695 $2K
84145 <1% 115 $2K
86615 <1% 1,096 $2K
99199 Unlisted special service, procedure or report <1% 644 $2K
80184 <1% 965 $2K
82530 <1% 1,213 $1K
84300 <1% 2,418 $1K
83605 <1% 1,206 $1K
86148 <1% 402 $1K
88302 <1% 74 $1K
G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous <1% 1,977 $1K
82384 <1% 1,096 $1K
85041 <1% 8,592 $1K
87102 <1% 619 $1K
86682 <1% 766 $1K
81015 <1% 1,897 $1K
86747 <1% 206 $1K
84597 <1% 1,173 $1K
83935 <1% 2,330 $1K
84163 <1% 4,792 $1K
83930 <1% 1,816 $1K
80158 <1% 292 $1K
82657 <1% 193 $1K
86617 <1% 403 $1K
83088 <1% 547 $1K
80165 <1% 848 $1K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 436 $991.99
83825 <1% 793 $981.33
87807 <1% 233 $957.83
85520 <1% 142 $928.72
86022 <1% 126 $903.39
80361 <1% 129,590 $880.94
80354 <1% 137,636 $873.77
80359 <1% 129,048 $861.49
80358 <1% 143,671 $860.40
80348 <1% 131,680 $857.49
86316 <1% 874 $844.13
80365 <1% 131,976 $820.65
87252 <1% 205 $817.19
80372 <1% 123,912 $817.16
83992 <1% 85,246 $807.53
80373 <1% 124,423 $805.01
81490 <1% 109 $798.95
80353 <1% 124,464 $787.01
84442 <1% 1,032 $776.44
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision <1% 561 $754.59
86606 <1% 240 $751.21
80355 <1% 66,840 $741.66
80364 <1% 68,860 $735.76
80344 <1% 66,061 $719.59
81517 <1% 44 $632.37
80337 <1% 73,559 $617.51
80367 <1% 68,890 $616.81
82180 <1% 364 $616.31
80370 <1% 75,905 $601.59
80326 <1% 65,728 $598.97
82175 <1% 603 $595.39
80368 <1% 76,851 $588.13
80338 <1% 73,533 $572.29
80346 <1% 47,992 $561.53
80334 <1% 73,461 $553.50
80377 <1% 65,669 $547.10
80331 <1% 65,579 $538.05
86340 <1% 347 $515.17
80341 <1% 65,650 $514.91
80366 <1% 66,503 $514.00
85385 <1% 82 $512.18
80357 <1% 68,583 $475.43
80360 <1% 76,148 $472.90
86790 <1% 609 $458.65
87581 <1% 244 $453.79
87486 <1% 236 $453.79
86804 <1% 78 $436.62
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed <1% 13 $431.63
87206 <1% 1,441 $424.64
80349 <1% 17,653 $417.97
85210 <1% 69 $396.60
87420 <1% 263 $391.10
86041 <1% 65 $380.75
80162 <1% 221 $379.86
80180 <1% 152 $351.34
82656 <1% 686 $333.36
80195 <1% 404 $323.24
87254 <1% 505 $294.07
86042 <1% 44 $289.34
80324 <1% 70,074 $271.15
80320 <1% 3,135 $268.90
80371 <1% 65,725 $265.10
85280 <1% 24 $263.15
80203 <1% 855 $258.94
80347 <1% 94,662 $241.97
84560 <1% 348 $241.60
81381 <1% 202 $228.10
84252 <1% 75 $207.02
83527 <1% 358 $203.86
83874 <1% 80 $202.52
80201 <1% 533 $190.36
84133 <1% 524 $185.74
86794 <1% 17 $184.31
80321 <1% 2,921 $175.45
82379 <1% 1,163 $175.41
88311 <1% 63 $169.40
G0475 Hiv antigen/antibody, combination assay, screening <1% 123 $164.30
85415 <1% 31 $148.93
87905 <1% 237 $142.34
84588 <1% 28 $139.72
87496 <1% 14 $139.59
86710 <1% 64 $138.10
87899 <1% 52 $133.34
86658 <1% 39 $132.29
87449 <1% 27 $132.05
84105 <1% 390 $125.75
88275 <1% 40 $125.19
81332 <1% 165 $120.03
88271 <1% 40 $114.29
84449 <1% 112 $110.28
84143 <1% 28 $109.96
86215 <1% 91 $102.45
87116 <1% 161 $100.35
86631 <1% 72 $94.06
86043 <1% 42 $88.80
87106 <1% 97 $84.79
82139 <1% 727 $78.31
84591 <1% 43 $63.38
86161 <1% 38 $61.18
80345 <1% 5,731 $57.74
84206 <1% 90 $56.72
82523 <1% 115 $54.85
85230 <1% 13 $53.19
80356 <1% 9,589 $52.17
84260 <1% 38 $50.73
89051 <1% 55 $45.20
86788 <1% 53 $35.90
87425 <1% 38 $33.45
86789 <1% 53 $30.67
89060 <1% 26 $29.51
82595 <1% 87 $28.52
83986 <1% 14 $23.13
83951 <1% 171 $22.99
82300 <1% 44 $22.81
80323 <1% 222 $18.24
83945 <1% 114 $17.75
82010 <1% 39 $17.55
82507 <1% 79 $16.48
87280 <1% 699 $15.28
87276 <1% 663 $14.17
87275 <1% 664 $14.17
86849 <1% 14 $13.22
84585 <1% 12 $9.18
80369 <1% 7,497 $7.32
80362 <1% 12,886 $7.15
82693 <1% 306 $6.64
80339 <1% 265 $6.58
86632 <1% 29 $6.57
80374 <1% 6,361 $5.00
80375 <1% 68 $3.66
82540 <1% 13 $3.03
82436 <1% 40 $2.56
81599 <1% 150 $1.36
S3600 Stat laboratory request (situations other than s3601) <1% 426 $0.92
0014M 0% 16 $0.00
82017 0% 69 $0.00
82360 0% 99 $0.00
81383 0% 12 $0.00
86609 0% 29 $0.00
83919 0% 12 $0.00
81244 0% 27 $0.00
87260 0% 656 $0.00
87299 0% 658 $0.00
87279 0% 659 $0.00
80235 0% 116 $0.00
82131 0% 13 $0.00
81443 0% 24 $0.00
80325 0% 14 $0.00
81500 0% 13 $0.00
82365 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWILLIAMS, KIMBERLY (VP)
Same official

Other billing entities under WILLIAMS, KIMBERLY

Full network →
ProviderLocationPaid
Laboratory Corporation of America HoldingsBurlington, NC$1.44B
Laboratory Corporation of America HoldingsRaritan, NJ$717.47M
Laboratory Corporation of America HoldingsDublin, OH$617.02M
Laboratory Corporation of America HoldingsBirmingham, AL$289.12M
Laboratory Corporation of America HoldingsBurlington, NC$264.26M
Laboratory Corporation of America HoldingsCharleston, WV$220.04M
Laboratory Corporation of AmericaSeattle, WA$186.69M
Laboratory Corporation of AmericaTampa, FL$171.13M
Laboratory Corporation of AmericaSan Diego, CA$147.14M
Laboratory Corporation of AmericaHouston, TX$103.81M
Laboratory Corporation of AmericaEnglewood, CO$77.80M
Laboratory Corporation of AmericaDallas, TX$77.42M
Laboratory Corporation of AmericaBurlington, NC$59.75M
Medtox Laboratories, INCSaint Paul, MN$47.72M
Laboratory Corporation of America HoldingsBurlington, NC$15.65M
Laboratory Corporation of AmericaSan Antonio, TX$11.67M
Tri-Cities Laboratory, LLCKennewick, WA$8.69M
Laboratory Corporation of America HoldingsMonroe, LA$3.39M
Laboratory Corporation of AmericaItasca, IL$3.37M
Laboratory Corporation of AmericaAlbany, NY$2.06M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.